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thrombin injection to prevent leakage. 3 Both these tech-
niques interrupt the flow into the distal artery and into the 
cavity during injection and may slow the process of throm-
bosis. All the methods have excellent success rates on small 
numbers of patients, and therefore, at this stage, no indi-
vidual technique can be considered superior in terms of 
efficacy or safety. 
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Reply 
We would like to thank the editors for the opportunity 
to respond to the letter by Drs Lennox, Griffen, Nicolaides, 
and Mansfield. Since the submission of our manuscript 
describing the initial experience with ultrasound scan-guid-
ed thrombin injection, we too have had a complication, but 
its cause was clear. After 1 injection of 0.5 mL of thrombin 
into a brachial artery pseudoaneurysm (1.9 x 0.8 x 0.5 cm), 
most of the pseudoaneurysm was thrombosed, but there 
was a persistent neck that was 0.3-cm wide and 0.4-cm 
long. Having become skilled at needle positioning, we 
placed the needle tip within this neck and injected another 
0.2 mL of thrombin with successful thrombosis. However, 
a few minutes later, hand ischemia developed in the patient 
and ultrasound scan showed thrombus occluding the distal 
brachial artery. The patient was already undergoing antico-
agulation therapy with heparin at the time, and an addi-
tional 5000 units were given. We scheduled the operating 
room to perform a thrombectomy, but a few minutes later, 
the patient's hand ischemia resolved completely. Ultrasound 
scan showed some residual thrombus along the wall of the 
brachial artery, and 3 days later, it had completely disap-
peared. A review of the videotape showed that some of the 
thrombin solution was injected directly into the artery. On 
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the basis of this experience, we do not further inject persis-
tent necks and 5 necks have been observed, with sponta-
neous thrombosis in 4 and a recurrent pseudoaneurysm the 
following day in 1. Overall, we have successfully treated 58 
of 59 pseudoaneurysms with this technique. 
We have had personal communications with a few 
other physicians who have encountered thrombosis of the 
femoral artery with limb ischemia after thrombin injec-
tion. All were successfully treated with intra-arterial uroki-
nase infusion. In each case, it seemed that too large a vol-
ume (several mL) of thrombin solution was injected. If the 
volume of thrombin solution injected exceeds the volume 
of the pseudoaneurysm, it is possible that some of it will 
be forced into the artery. Too rapid an injection also could 
cause this problem. We recommend initial injection of a 
small volume of thrombin, especially for smaller pseudo-
aneurysms. Currently, we rarely inject more than 0.5 mL. 
However, we do not think that a more dilute thrombin 
solution would be necessarily safer. The high concentra-
tion that we use causes rapid conversion of the solution 
into a solid (thrombus) and decreases the possibility that 
some of the solution will flow into the artery. 
The cause of the complication in the case presented by 
Dr Lennox is less clear. The brachial artery of a lO-month-
old child is probably only 2 to 3 mm in diameter. The hole 
in the artery may have been almost as large as the arterial 
diameter. After successful thrombosis of the pseudo-
aneurysm, there would be thrombus filling the neck and cov-
ering the arterial defect. Thrombin trapped within thrombus 
is still active, and therefore, its surface is thrombogenic. 
Thrombus that forms in response to thrombin injection may 
be more thrombogenic than naturally occurring thrombus. 
This thrombogenic material would be exposed to the lumi-
nal surface of the artery, and because of the small size of the 
artery, could comprise a significant portion of the luminal 
area and cause thrombosis of the artery. For the same reason, 
the incidence rate of arterial thrombosis after catheterization 
is higher in infants and in smaller arteries of adults. One 
could avoid this complication by not using this technique for 
pseudoaneurysms of small arteries. If the above hypothesis is 
correct, the maneuvers mentioned by Dr Lennox (com-
pressing the neck or inflating an intra-arterial balloon 
catheter during thrombin injection) would not prevent this 
complication. Anticoagulation therapy with heparin during 
and after thrombin injection may be a better option. 
Treatment of this complication needs to be individual-
ized, and the degree of ischemia, the extent and location of 
the thrombosis, whether the aneurysm is patent or occlud-
ed, and the condition of the patient must be taken into 
consideration. We applaud Dr Lennox and his colleagues 
for the successful resolution of a difficult complication. 
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